SCHEMBL8993333

SCHEMBL8993333

COc1ccc(C(O)CNCc2cccc(OC)c2OC)cc1OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
OPRK1 P41145 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
ATM Q13315 1/20 0.48
POLB P06746 1/20 0.48
GAA P10253 1/20 0.48
TSHR P16473 1/20 0.48
CRHBP P24387 1/20 0.48
MAPK1 P28482 1/20 0.48
CRHR2 Q13324 1/20 0.48
ADRB2 P07550 3/20 0.47
DRD2 P14416 2/20 0.47
DRD1 P21728 2/20 0.47
DRD4 P21917 2/20 0.47
DRD3 P35462 2/20 0.47
ADRB1 P08588 1/20 0.47
BCHE P06276 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11102216 0.88 MEN1 (0.59) ALDH1A1KDM4EOPRK1KMT2AMEN1
SCHEMBL8905807 0.88 OPRK1 (0.48) ALDH1A1OPRK1KMT2AMEN1TSHR
SCHEMBL27137674 0.86 BCHE (0.59) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL8907016 0.84 ADRB2 (0.51) ALDH1A1KDM4EOPRK1KMT2AMEN1
SCHEMBL11098569 0.82 OPRK1 (0.54) ALDH1A1OPRK1KMT2AMEN1TSHR
SCHEMBL11099823 0.82 ADRB2 (0.50) ALDH1A1OPRK1KMT2AMEN1TSHR
SCHEMBL8906035 0.82 OPRK1 (0.44) ALDH1A1KDM4EOPRK1KMT2AMEN1
SCHEMBL8905842 0.81 MAPT (0.47) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL11099951 0.79 ADRB2 (0.61) ALDH1A1OPRK1KMT2AMEN1TSHR
SCHEMBL11268795 0.78 ALDH1A1 (0.60) ALDH1A1KDM4EKMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0476156-B1 SOLID ORAL PREPARATION CONTAINING CATECHOL COMPOUND EISAI CO LTD (JP) 1996-08-07 EP disclosed
US-5378849-A Kidney vasodilators; orally administered YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1995-01-03 US disclosed
US-5292521-A And an organic acid or salt EISAI CO., LTD. (JP) 1994-03-08 US disclosed
US-5204468-A Nephrovascular dilators and diuretics; side effect reduction; administered by mouth YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1993-04-20 US disclosed
EP-0286293-B1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS, THEIR PRODUCTION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1992-07-01 EP disclosed
EP-0476156-A1 SOLID ORAL PREPARATION CONTAINING CATECHOL COMPOUND Eisai Co., Ltd. (JP) 1992-03-25 EP disclosed
US-5079256-A Administering to treat diseases of circulatory organs such as renal/cardiac insufficiency YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1992-01-07 US disclosed
US-5077406-A Cyclization, deprotecting and salt formation YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1991-12-31 US disclosed
US-4966904-A DILUROGENITAL DISORDERS; DILATION OF NEOPHROVASCULAR TRACTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1990-10-30 US disclosed
US-4876261-A UROGENITAL DISORDERS; NEPHROVASCULAR DILATORS; ACT ON DOPAMINE RECEPTOR YAMANOUCHI PHARMACEUTICAL CO., LTD. 1989-10-24 US disclosed
EP-0286293-A1 Substituted tetrahydroisoquinoline compounds, their production, and pharmaceutical compositions containing them YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1988-10-12 EP disclosed